These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 8821067

  • 1. Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease.
    Jellinger K, Linert L, Kienzl E, Herlinger E, Youdim MB.
    J Neural Transm Suppl; 1995; 46():297-314. PubMed ID: 8821067
    [Abstract] [Full Text] [Related]

  • 2. Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease.
    Linert W, Herlinger E, Jameson RF, Kienzl E, Jellinger K, Youdim MB.
    Biochim Biophys Acta; 1996 Aug 23; 1316(3):160-8. PubMed ID: 8781534
    [Abstract] [Full Text] [Related]

  • 3. Iron- and manganese-catalyzed autoxidation of dopamine in the presence of L-cysteine: possible insights into iron- and manganese-mediated dopaminergic neurotoxicity.
    Shen XM, Dryhurst G.
    Chem Res Toxicol; 1998 Jul 23; 11(7):824-37. PubMed ID: 9671546
    [Abstract] [Full Text] [Related]

  • 4. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V, Tan EM, Liebau S, Lenk T, Zettlmeisl H, Schwarz J, Storch A.
    Neurochem Int; 2006 Apr 23; 48(5):329-40. PubMed ID: 16406146
    [Abstract] [Full Text] [Related]

  • 5. Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson's disease.
    Pezzella A, d'Ischia M, Napolitano A, Misuraca G, Prota G.
    J Med Chem; 1997 Jul 04; 40(14):2211-6. PubMed ID: 9216840
    [Abstract] [Full Text] [Related]

  • 6. New insights into iron release from ferritin: direct observation of the neurotoxin 6-hydroxydopamine entering ferritin and reaching redox equilibrium with the iron core.
    Jameson GN, Jameson RF, Linert W.
    Org Biomol Chem; 2004 Aug 21; 2(16):2346-51. PubMed ID: 15305217
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of transition metals in the pathogenesis of Parkinson's disease.
    Kienzl E, Puchinger L, Jellinger K, Linert W, Stachelberger H, Jameson RF.
    J Neurol Sci; 1995 Dec 21; 134 Suppl():69-78. PubMed ID: 8847547
    [Abstract] [Full Text] [Related]

  • 9. Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease?
    Kienzl E, Jellinger K, Stachelberger H, Linert W.
    Life Sci; 1999 Dec 21; 65(18-19):1973-6. PubMed ID: 10576448
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.
    Liu CQ, Chen Z, Liu FX, Hu DN, Luo JH.
    Neuropharmacology; 2007 Dec 21; 53(7):832-41. PubMed ID: 17919665
    [Abstract] [Full Text] [Related]

  • 15. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
    Fleming SM, Delville Y, Schallert T.
    Behav Brain Res; 2005 Jan 30; 156(2):201-13. PubMed ID: 15582106
    [Abstract] [Full Text] [Related]

  • 16. A proteomic approach in the study of an animal model of Parkinson's disease.
    De Iuliis A, Grigoletto J, Recchia A, Giusti P, Arslan P.
    Clin Chim Acta; 2005 Jul 24; 357(2):202-9. PubMed ID: 15946658
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats.
    Henze C, Earl C, Sautter J, Schmidt N, Themann C, Hartmann A, Oertel WH.
    Brain Res; 2005 Aug 02; 1052(1):97-104. PubMed ID: 16005444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.